ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Facilitating Shared Decisionmaking About Prostate Cancer Screening

This study has been completed.

Sponsored by: Department of Veterans Affairs
Information provided by: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00013247
  Purpose

Due to the disputed efficacy of prostate cancer (CaP) screening and treatment, most authorities recommend that providers inform and involve patients in CaP screening decisions.


Condition Intervention
Prostate Cancer
Behavioral: Prostate Cancer Screening Education

MedlinePlus related topics:   Cancer    Prostate Cancer   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Single Blind, Active Control, Single Group Assignment, Efficacy Study
Official Title:   Facilitating Shared Decisionmaking About Prostate Cancer Screening

Further study details as provided by Department of Veterans Affairs:

Estimated Enrollment:   1152
Study Completion Date:   December 2002

Arms Assigned Interventions
1 Behavioral: Prostate Cancer Screening Education

Detailed Description:

Background:

Due to the disputed efficacy of prostate cancer (CaP) screening and treatment, most authorities recommend that providers inform and involve patients in CaP screening decisions.

Objectives:

This study evaluated two interventions designed to facilitate this process.

Methods:

1152 male veterans age 50+ with no CaP and primary care appointments at four VA medical facilities in VISN 23 were randomly assigned to one of three groups: mailed pamphlet intervention, mailed video intervention, or usual care (control). Intervention materials were mailed two weeks prior to a target primary care appointment and patient telephone surveys were conducted one week (T1) and one year (T2) after the target appointment. Outcomes included: a 10- item validated knowledge index; responses to questions on CaP natural history, treatment efficacy, PSA accuracy, and expert disagreement about the PSA; whether screening was discussed with provider; scores on decision information seeking, participation and satisfaction scales; screening and treatment preferences; and PSA testing rates.

Status:

Complete

  Eligibility
Ages Eligible for Study:   50 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

Patients must be male veterans, age 50 and older, with a scheduled primary care appointment at one of 5 VISN 13 medical facilities. Patients diagnosed with prostate cancer will be excluded.

Exclusion Criteria:

  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00013247

Locations
United States, Minnesota
VA Medical Center    
      Minneapolis, Minnesota, United States, 55417

Sponsors and Collaborators

Investigators
Principal Investigator:     Melissa R. Partin, PhD     Department of Veterans Affairs    
  More Information


Publications of Results:

Responsible Party:   Department of Veterans Affairs ( Partin, Melissa - Principal Investigator )
Study ID Numbers:   IIR 99-277
First Received:   March 14, 2001
Last Updated:   August 15, 2008
ClinicalTrials.gov Identifier:   NCT00013247
Health Authority:   United States: Federal Government

Study placed in the following topic categories:
Prostatic Diseases
Genital Neoplasms, Male
Urogenital Neoplasms
Genital Diseases, Male
Prostatic Neoplasms

Additional relevant MeSH terms:
Neoplasms
Neoplasms by Site

ClinicalTrials.gov processed this record on October 07, 2008




Links to all studies - primarily for crawlers